Cargando…

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer

Wild-type p53 competitively binds to the promoter region of COX-2 in vitro and inhibits its transcription. We examined the association between p53 mutation and COX-2 expression in gastric cancer. COX-2 over-expression was seen in 19 (48.7%) cases. These tumours had more lymph-node metastasis (P = 0....

Descripción completa

Detalles Bibliográficos
Autores principales:	Leung, W K, To, K-F, Ng, Y-P, Lee, T-L, Lau, J Y W, Chan, F K L, Ng, E K W, Chung, S C S, Sung, J J Y
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363738/ https://www.ncbi.nlm.nih.gov/pubmed/11161397 http://dx.doi.org/10.1054/bjoc.2000.1607

Ejemplares similares

Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor
por: Tian, X X, et al.
Publicado: (1999)

Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation
por: Sakakura, C, et al.
Publicado: (2001)

Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer
por: Leung, W K, et al.
Publicado: (2005)

Prognostic value of p53 protein expression for patients with gastric cancer – a multivariate analysis
por: Maehara, Y, et al.
Publicado: (1999)

Specific desensitization of the canine renal vasculature to angiotensin II despite cyclo-oxygenase inhibition.
por: Meggs, L. G., et al.
Publicado: (1985)

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
por: Wu, C-W, et al.
Publicado: (1999)

Microsatellite instability, Epstein–Barr virus, mutation of type II transforming growth factor β receptor and BAX in gastric carcinomas in Hong Kong Chinese
por: Leung, S Y, et al.
Publicado: (1999)

The role of carbon monoxide and heme oxygenase-1 in COVID-19
por: Kwong, Kenneth K., et al.
Publicado: (2020)

Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer
por: Cheng, Y Y, et al.
Publicado: (2008)

The association between cyclo-oxygenase-2 expression and cell proliferation and angiogenesis in human breast cancer
por: Kirkpatrick, K, et al.
Publicado: (2001)

Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer
por: Li, J, et al.
Publicado: (2009)

Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity
por: Jones, D J L, et al.
Publicado: (2004)

The in vitro free radical scavenging activity of tenidap, a new dual cyclo-oxygenase and 5-1ipoxygenase inhibitor
por: Lau, C. S., et al.
Publicado: (1992)

Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis
por: Shinohara, H, et al.
Publicado: (2000)

Cyclooxygenase-1-selective inhibitor SC-560
por: Long, Sihui, et al.
Publicado: (2009)

Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection
por: Choi, J-H, et al.
Publicado: (2001)

Gastric cancer with p53 overexpression has high potential for metastasising to lymph nodes.
por: Kakeji, Y., et al.
Publicado: (1993)

Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice
por: Kitadai, Y, et al.
Publicado: (1999)

Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line
por: To, K F, et al.
Publicado: (2004)

The expression of p73 is increased in lung cancer, independent of p53 gene alteration
por: Tokuchi, Y, et al.
Publicado: (1999)

Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer
por: Tanaka, F, et al.
Publicado: (2001)

Increased expression of survivin in gastric cancer patients and in first degree relatives
por: Yu, J, et al.
Publicado: (2002)

Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma
por: Wang, G L, et al.
Publicado: (1999)

A tumour-associated cell-surface glycoprotein accompanying p53 overexpression and higher growth potential for gastric cancer.
por: Maehara, Y., et al.
Publicado: (1995)

Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer
por: Wu, X, et al.
Publicado: (1999)

A novel missense mutation in CCDC88C activates the JNK pathway and causes a dominant form of spinocerebellar ataxia
por: Tsoi, Ho, et al.
Publicado: (2014)

p53 protein overexpression and allele loss of p53 gene in gastric adenocarcinoma.
por: Choi, S. W., et al.
Publicado: (1994)

p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.
por: Yoon, K. S., et al.
Publicado: (2001)

Overexpression of SPARC gene in human gastric carcinoma and its clinic–pathologic significance
por: Wang, C-S, et al.
Publicado: (2004)

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer
por: Ferrandina, G, et al.
Publicado: (1999)

Impaired cerebral blood flow in type 2 diabetes mellitus – A comparative study with subjective cognitive decline, vascular dementia and Alzheimer’s disease subjects
por: Chau, Anson C.M., et al.
Publicado: (2020)

p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas
por: Mousses, S, et al.
Publicado: (2001)

Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer
por: Maehara, Y, et al.
Publicado: (2000)

Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer
por: Sato, K, et al.
Publicado: (2001)

Overexpression of p53 in different subtypes of intestinal metaplasia and gastric cancer.
por: Wu, M. S., et al.
Publicado: (1998)

Paradoxical regulation of Bcl-2 family proteins by 17β-oestradiol in human breast cancer cells MCF-7
por: Leung, L K, et al.
Publicado: (1999)

Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours
por: Nakagawa, Y, et al.
Publicado: (1999)

Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers
por: Chang, K-W, et al.
Publicado: (2004)

Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000)

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma
por: Hu, Y-X, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_759r6l38vt8o3q4s87fj11gd7p